Logo - springer
Slogan - springer

Biomedical Sciences - Cancer Research | Cancer Microenvironment (Editorial Board)

Cancer Microenvironment

Cancer Microenvironment

Official Journal of the International Cancer Microenvironment Society

Editor-in-Chief: Isaac Witz

ISSN: 1875-2292 (print version)
ISSN: 1875-2284 (electronic version)

Journal no. 12307

80,33 € Personal Rate e-only
Get Subscription

Online subscription, valid from January through December of current calendar year

Immediate access to this year's issues via SpringerLink

1 Volume(-s) with 3 issue(-s) per annual subscription

Automatic annual renewal

More information: >> FAQs // >> Policy

Isaac P. Witz, PhD
Professor of Immunology
President of the International Tumor Microenviroment Society
Tel Aviv University
Tel Aviv, Israel

Editorial Board

Adriana Albini, IRCCS Multimedica Science and Technology Park, Milan, Italy;
Ron Apte, Ben-Gurion University of the Negev, Beer-Sheva, Israel;
Frances Balkwill, Queen Mary, University of London, UK;
Richard Bankert, University at Buffalo, NY, USA;
Menashe Bar-Eli, MD Anderson Cancer Center, Houston,TX, USA;
Adit Ben-Baruch, Tel Aviv University, Israel;
Mina J. Bissell, Lawrence Berkeley National Laboratory, Berekley ,CA, USA;
Subhra K. Biswas, Singapore Immunology Network, Singapore;
Joan Brugge, Harvard Medical School, Boston, MA, USA;
Francesca Caccuri, University of Brescia, Italy
Leland Chung, Cedars-Sinai Medical Center, Los Angeles, CA,USA
Lisa Coussens, Oregon Health and Science University, Portland, OR, USA;  
Yves DeClerck, Children’s Hospital Los Angeles, CA, USA;
Isaiah Fidler, MD Anderson Cancer Center, Houston, TX, USA;
Wolf Fridman, Cordelier Research Center, Paris, France;
Raffaella Giavazzi, Mario Negri Institute for Pharmacological Research, Milan, Italy;
Mary J.C. Hendrix, Northwestern University Feinberg School of Medicine, Chicago, IL, USA;
Meenhard Herlyn
, The Wistar Institute, Philadelphia, PA, USA;
Richard Hill, University of Toronto, ON, Canada;
Jacques Huot, Laval University Cancer Research Center, Québec, Canada;
Nathan Karin, Dept. of Immunology, Rappaport Faculty of Medicine Technion- Israel Institute of Technology, Haifa, Israel;
Yona Keisari, Tel Aviv University, Israel
Eva Klein, Karolinska Institute, Stockholm, Sweden;
Yoel Kloog, Tel Aviv University, Israel;
Luyuan Li, Nankai University College of Pharmaceutical Science, Tianjin, China;
Michael P. Lisanti, Thomas Jefferson University, Philadelphia, PA, USA;
Michael Lotze, University of Pittsburgh Medical Center, PA,  USA;
Alberto Mantovani, University of Milan, Italy;
Dario Marchetti, Baylor College of Medicine, Houston, TX, USA; 
Ruth J. Muschel
, Gray Institute for Radiation Oncology and Biology, Oxford, UK;
Margareta Mueller, German Cancer Research Center, Heidelberg, Germany;
Suresh Mohla, National Cancer Institute, NIH, Rockville, USA;
Harold L. Moses, Vanderbilt University School of Medicine, Nashville, TN, USA
Jeffrey Pollard, University of Edinburgh, UK;
Kornelia Polyak, Harvard Medical School, Boston, MA USA;
Jacques Pouysségur, Institute of Research on Cancer and Aging, Nice, France;
Laszlo Radvanyi,
University of Texas MD Anderson Cancer Center, Houston, TX, USA; 
Avraham Raz
, Wayne State University, Detroit, MI, USA;
Antonio Sica, Humanitas Clinical and Research Center, Milan, Italy;
Yuval Shaked, Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel;
Michael R. Shurin, University of Pittsburgh Medical Center, PA, USA;
Jonathan P. Sleeman, University of Heidelberg, Mannheim, Germany;
Benjamin Sredni, Bar Ilan University, Ramat Gan, Israel;
Eiichi Tahara, Hiroshima Cancer Seminar Foundation, Japan;
David Tarin, University of California, La Jolla, CA, USA;
Andrei Thomas-Tikhonenko, University of Pennsylvania, PA,USA;
Giorgio Trinchieri, Center for Cancer Research, Frederick, MD, USA;
Fernando Vidal Vanaclocha, University of the Basque Country, Leioa, Spain;
Israel Vlodavsky, Cancer and Vascular Biology Research Center, Israel;
Danny R. Welch, The University of Kansas Cancer Center, USA;
Theresa Whiteside, University of Pittsburgh School of Medicine, USA;
Yosef Yarden, Weizmann Institute of Science, Rehovot, Israel;
Eitan Yefenof, Hebrew University, Jerusalem, Israel;
Jan Zeromski, University of Medical Sciences, Poznań, Poland;
Dov Zipori, Weizmann Institute of Science, Rehovot, Israel;
Bruce Zetter, Children's Hospital Boston, USA;
Weiping Zou, University of Michigan School of Medicine, Ann Arbor, USA

Read this Journal on Springerlink

For authors and editors

  • Aims and Scope

    Aims and Scope


    Cancer Microenvironment is the official journal of the International Cancer Microenvironment Society (ICMS). It publishes original articles, reviews, short communications, commentaries and letters to the Editor in all aspects of basic, clinical and translational research devoted to the study of cancer microenvironment. Topics include: Regulation of gene expression in the cancer microenvironment; innate and adaptive immunity in the cancer microenvironment, inflammation and cancer; tumor-associated stroma & extracellular matrix, tumor-endothelium interactions (angiogenesis, extravasation), cancer stem cells, the metastatic niche, targeting the tumor microenvironment: preclinical and clinical trials. The publication of reports on clinical trials is highly encouraged.

  • Submit Online
  • Open Choice - Your Way to Open Access
  • Instructions for authors

    Instructions for authors


  • Author Academy: Training for Authors
  • Copyright Information

    Copyright Information


    Copyright Information

    For Authors

    Submission of a manuscript implies: that the work described has not been published before (except in form of an abstract or as part of a published lecture, review or thesis); that it is not under consideration for publication elsewhere; that its publication has been approved by all co-authors, if any, as well as – tacitly or explicitly – by the responsible authorities at the institution where the work was carried out.

    Author warrants (i) that he/she is the sole owner or has been authorized by any additional copyright owner to assign the right, (ii) that the article does not infringe any third party rights and no license from or payments to a third party is required to publish the article and (iii) that the article has not been previously published or licensed. The author signs for and accepts responsibility for releasing this material on behalf of any and all co-authors. Transfer of copyright to Springer (respective to owner if other than Springer) becomes effective if and when a Copyright Transfer Statement is signed or transferred electronically by the corresponding author. After submission of the Copyright Transfer Statement signed by the corresponding author, changes of authorship or in the order of the authors listed will not be accepted by Springer.

    The copyright to this article, including any graphic elements therein (e.g. illustrations, charts, moving images), is assigned for good and valuable consideration to Springer effective if and when the article is accepted for publication and to the extent assignable if assignability is restricted for by applicable law or regulations (e.g. for U.S. government or crown employees).

    The copyright assignment includes without limitation the exclusive, assignable and sublicensable right, unlimited in time and territory, to reproduce, publish, distribute, transmit, make available and store the article, including abstracts thereof, in all forms of media of expression now known or developed in the future, including pre- and reprints, translations, photographic reproductions and microform. Springer may use the article in whole or in part in electronic form, such as use in databases or data networks for display, print or download to stationary or portable devices. This includes interactive and multimedia use and the right to alter the article to the extent necessary for such use.

    Authors may self-archive the Author's accepted manuscript of their articles on their own websites. Authors may also deposit this version of the article in any repository, provided it is only made publicly available 12 months after official publication or later. He/she may not use the publisher's version (the final article), which is posted on SpringerLink and other Springer websites, for the purpose of self-archiving or deposit. Furthermore, the Author may only post his/her version provided acknowledgement is given to the original source of publication and a link is inserted to the published article on Springer's website. The link must be accompanied by the following text: "The final publication is available at link.springer.com".

    Prior versions of the article published on non-commercial pre-print servers like arXiv.org can remain on these servers and/or can be updated with Author's accepted version. The final published version (in pdf or html/xml format) cannot be used for this purpose. Acknowledgement needs to be given to the final publication and a link must be inserted to the published article on Springer's website, accompanied by the text "The final publication is available at link.springer.com". Author retains the right to use his/her article for his/her further scientific career by including the final published journal article in other publications such as dissertations and postdoctoral qualifications provided acknowledgement is given to the original source of publication.

    Author is requested to use the appropriate DOI for the article. Articles disseminated via link.springer.com are indexed, abstracted and referenced by many abstracting and information services, bibliographic networks, subscription agencies, library networks, and consortia.

    For Readers

    While the advice and information in this journal is believed to be true and accurate at the date of its publication, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may have been made. The publisher makes no warranty, express or implied, with respect to the material contained herein.

    All articles published in this journal are protected by copyright, which covers the exclusive rights to reproduce and distribute the article (e.g., as offprints), as well as all translation rights. No material published in this journal may be reproduced photographically or stored on microfilm, in electronic data bases, video disks, etc., without first obtaining written permission from the publisher (respective the copyright owner if other than Springer). The use of general descriptive names, trade names, trademarks, etc., in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

    Springer has partnered with Copyright Clearance Center's RightsLink service to offer a variety of options for reusing Springer content. For permission to reuse our content please locate the material that you wish to use on link.springer.com or on springerimages.com and click on the permissions link or go to copyright.com, then enter the title of the publication that you wish to use. For assistance in placing a permission request, Copyright Clearance Center can be connected directly via phone: +1-855-239-3415, fax: +1-978-646-8600, or e-mail: info@copyright.com.

    © Springer Science+Business Media Dordrecht

Alerts for this journal


Get the table of contents of every new issue published in Cancer Microenvironment.